Results 151 to 160 of about 23,381 (306)

Correction to: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?

Osteoporosis International, 2023
T. Hasegawa, A. Kawakita, N. Ueda, R. Funahara, A. Tachibana, M. Kobayashi, E. Kondou, D. Takeda, Y. Kojima, S. Sato, S. Yanamoto, H. Komatsubara, M. Umeda, T. Kirita, H. Kurita, Y. Shibuya, T. Komori, Japanese Study Group of Co-operative Dentistry with Medicine   +17 more
semanticscholar   +1 more source

Correction: Attitudes and perceptions of GPs and community pharmacists towards their role in the prevention of bisphosphonate-related osteonecrosis of the jaw: a qualitative study in the North East of England [PDF]

, 2017

openalex   +1 more source

Bisphosphonate-related osteonecrosis of the jaw in a patient with osteoporosis following treatment of testicular cancer: a case report [PDF]

, 2015
Do-Sup Kim, Jung-Ho Kim, Joo‐Young Ohe, Jung‐Woo Lee, Byung-Jun Choi, Baek‐Soo Lee, Yong‐Dae Kwon   +6 more
openalex   +1 more source

Bone mineral density measurements performed by cone-beam computed tomography in the bisphosphonate-related osteonecrosis-affected jaw [PDF]

, 2018
Objectives: The aims of this study were to determine the bone mineral density (BMD) in bisphosphonate-related osteonecrosis of the jaw (BRONJ) by cone-beam computed tomography (CBCT) measurements and to correlate these measurements with the current ...
Grätz, Klaus, Guggenberger, Roman, Jacobsen, Christine, Lübbers, Heinz-Theo, Lüssi, Anja, Metzler, Philipp, Obwegeser, Joachim, Zemann, Wolfgang   +7 more
core  

Implications in dental treatment during the use of antiresorptive drugs - a literature review

Journal of Education, Health and Sport
Introduction: Antiresorptive drugs such as bisphosphonates and denosumab are crucial for treating osteoporosis, metastatic bone disease, and hypercalcemia by inhibiting osteoclast function.
Aleksandra Dziewulska, Weronika Kiełt, Julia Kozłowska, Gabriela Broniec, Barbara Wajdowicz, Aleksandra Kudła, Rozalia Czapiewska, Aleksandra Wróbel, Laura Pacek, Klaudia Kowalska   +9 more
doaj   +1 more source

Bilateral Orocutaneous Fistulas and Mandibular Osteonecrosis

International Journal of Dermatology, Volume 65, Issue 2, Page 374-375, February 2026.
Krisztian Nemeth, Mollye Goldberg, Zachary Fridirici   +2 more
wiley   +1 more source

[Osteonecrosis of the jaw associated with long time withdrawal of bisphosphonates in multiple myeloma: one case report].

, 2016
Wenjun Yu, Xiaoyan Qu, Qinglin Shi, Yahui Yuan, Jiadai Xu, Jianyong Li, Lijuan Chen   +6 more
openalex   +2 more sources

Ultrasonic Navigation for the Treatment of Medication-Related Jaw Osteonecrosis Involving the Inferior Alveolar Nerve: A Case Report and Protocol Review [PDF]

, 2020
Gerardo Pellegrino, Francesca Pavanelli, Agnese Ferri, Giuseppe Lizio, Roberto Parrulli, Claudio Marchetti   +5 more
openalex   +1 more source

Osteonecrosis of the Jaw and Bilateral Atypical Femoral Fracture Both Occurring During Treatment for Osteoporosis: A Case Report

Journal of the ASEAN Federation of Endocrine Societies, 2018
Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) are rare potential adverse effects of bisphosphonates and RANKL antibody therapy. The pathogenic mechanisms of both conditions are known to be independent of each other.
Edelissa Payumo, Beinjerinck Ivan Cudal, Thelma Crisostomo   +2 more
doaj  

Case Report: Development of medication-related osteonecrosis of the jaw in a patient on long-term infliximab therapy

Frontiers in Oral Health
Medication-Related Osteonecrosis of the Jaw (MRONJ) is a challenging and evolving aspect of Oral and Maxillofacial Surgery. In recent years, several medications apart from those traditionally associated with MRONJ such as bisphosphates (BPs) and ...
Derek Oryniak, Meagan Brown, Lillie Cholakis, Reda Elgazzar   +3 more
doaj   +1 more source